665 related articles for article (PubMed ID: 22468752)
1. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
[TBL] [Abstract][Full Text] [Related]
5. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antitumor screening of certain novel tetrahydroquinoline sulfonamides.
Alafeefy AM
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):189-94. PubMed ID: 24666309
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 4-anilinoquinazoline bioisosteres as potential anti-breast cancer agents.
El-Ansary AK; Kamal AM; Al-Ghorafi MA
Eur J Med Chem; 2014 Oct; 86():202-10. PubMed ID: 25151582
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
Luo H; Yang S; Cai Y; Peng Z; Liu T
Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
He J; Wang X; Zhao X; Liang Y; He H; Fu L
Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of Some Dibromoquinazoline-sulphonamide Hybrids and some Schiff´s Base Analogs for their Cytotoxic Activity.
Ahmed MF; El-Haggar R
Anticancer Agents Med Chem; 2017 Nov; 17(11):1563-1569. PubMed ID: 28356022
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole.
Paul K; Sharma A; Luxami V
Bioorg Med Chem Lett; 2014 Jan; 24(2):624-9. PubMed ID: 24360999
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.
Li DD; Fang F; Li JR; Du QR; Sun J; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Sep; 22(18):5870-5. PubMed ID: 22901387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
